LIPELLA PHARMACEUTICALS INC. SBIR Phase II Award, May 2017
A SBIR Phase II contract was awarded to Lipella Pharmaceuticals in May, 2017 for $998,466.0 USD from the U.S. Department of Health & Human Services.
Is a
Award Amount (USD)
998,466
0
Date Awarded
May 5, 2017
0
End Date
April 30, 2020
0
SBIR/STTR Award Recipient
Contract Number (US Government)
2SB1DK102247-04A1
0
Award Phase
Phase II
0
Award Type
SBIR
0
Official Website
Find more entities like LIPELLA PHARMACEUTICALS INC. SBIR Phase II Award, May 2017
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.